Therapeutic opportunities for castration-resistant prostate cancer patients with bone metastases-Reference-Cited by-同舟云学术

Therapeutic opportunities for castration-resistant prostate cancer patients with bone metastases

Published:2014-08 Issue:2 Volume:91 Page:197-209
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Zustovich Fable,Fabiani Francesca

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference83 articles.

1. CancerMondial: summary table by population. International Agency for Research on Cancer. American cancer society cancer facts & figures 2009;database G,2009

2. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

3. Combined androgen blockade;Crawford;Urology,1989

4. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer;Eisenberger;N Engl J Med,1998

5. Combining docetaxel with estramustine: back to the future?;Oudard;J Clin Oncol,2009

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Castration-resistant prostate cancer with bone metastases: toward the best therapeutic choice;Medical Oncology;2022-07-14

2. Nuclear Medicine Therapy With 223Radium-dichloride for Osseous Metastases in Prostate Carcinoma;American Journal of Clinical Oncology;2019-01

3. Non-opioid Intravenous Infusions for Management of Cancer-Associated Pain;Essentials of Interventional Cancer Pain Management;2018-12-29

4. Pain predicts overall survival in men with metastatic castration-resistant prostate cancer treated with radium-223;OncoTargets and Therapy;2018-12

5. Design and Evaluation of Europium Containing Mesoporous Bioactive Glass Nanospheres: Doxorubicin Release Kinetics and Inhibitory Effect on Osteosarcoma MG 63 Cells;Nanomaterials;2018-11-21